Previous 10 | Next 10 |
Agilent (NYSE: A ): Q2 Non-GAAP EPS of $0.71 misses by $0.01 ; GAAP EPS of $0.57 misses by $0.06 . Revenue of $1.24B (+2.5% Y/Y) misses by $30M . Shares -6.7% . Press Release More news on: Agilent Technologies, Inc., Earnings news and commentary, Healthcare stocks news,
A , ACB , DOX , EGHT , FSM , NEWR , PAGS , TCS , TLRY For Seeking Alpha's full earnings season calendar, click here . More news on: Agilent Technologies, Inc., Aurora Cannabis Inc., Amdocs Limited, Earnings news and commentary,
This article is part of a series that provides an ongoing analysis of the changes made to William Von Mueffling’s 13F stock portfolio on a quarterly basis. It is based on Mueffling’s regulatory 13F Form filed on 05/01/2019. Please visit our Tracking William Von Mueffling's Can...
Innovative solution provides cell-based tools for translational research and development Agilent Technologies Inc. (NYSE: A) announces a unified portfolio of products for immunotherapy researchers. The innovative solution will showcase at Immunology 2019 , the 103 rd Annual Mee...
Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development Agilent Technologies, Inc. (NYSE: A) and SomaLogic, Inc. (a privately held biotechnology company...
Life sciences toolmaker Waters (NYSE: WAT ) is down 14% premarket on light volume after reporting Q1 results that were shy of expectations due to softness in China and Europe and the "slow release of budgets" from key corporate customers. Cash flow ops was flat yoy. More ne...
PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With KEYTRUDA ® (pembrolizumab) Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has updated its approval of the company...
The new xCELLigence RTCA ePacer provides a solution that uses electrical pacing to functionally mature cardiomyocytes. On March 11, 2019, ACEA Biosciences – A Part of Agilent unveiled the new xCELLigence® RTCA ePacer TM during their workshop held at the Society of Toxic...
Agilent Technologies Inc. (NYSE: A) will release second-quarter fiscal 2019 financial results after the stock market closes on May 14. The company will host a live webcast of its investor conference call in listen-only mode. Listeners may log on and select “Q2 2019 Agilent Te...
Increased capabilities for food testing, environmental screening, and metabolomics research with new systems and software workflows Agilent Technologies Inc. (NYSE: A) today announced a range of new products designed to deliver improved analytical and business outcomes for laboratorie...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
MAGE-A4 IHC 1F9 pharmDx is indicated as an aid in identifying patients with synovial sarcoma for whom TECELRA ® , a MAGE-A4-directed engineered T-Cell Receptor (TCR) therapy is being considered Agilent Technologies Inc. , (NYSE: A) today announced that it has received FDA a...
2024-08-01 15:15:03 ET William Blair analyst issues OUTPERFORM recommendation for A on August 1, 2024 01:31PM ET. The previous analyst recommendation was Outperform. A was trading at $143.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operatio...